2 Einträge von 2 mit function data
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords haemophilia from | phase japan | specialty market | study rviii | with immunoglobulins | patients clinical | products prophylaxis | bleeding breakthrough | rix-fp development | global medicines |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
functional activity (%) 40 IU/kg 1000 IU 60 IU/kg 40% activity SC low IU/kg SC high IU/kg IV 1000 IU/kg Specialty 59 CSL830 Program Progress • Phase III study rapidly completed enrollment (n=90) • Patients moving into extension study o Allowed for in data, CSL Actuals FY15 Total Global Market Value: ~$8.0B Immunoglobulins 42 CSL’s Global Performance CSL FY15 Sales $2.326B Key Brands: SCIG Hyper IVIG Immunoglobulins 43 0 20 40 60 80 100 120 140 India Thailand Russia Taiwan Braz
Text Inhalt Text aus URL
Log Metriken 446029
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords haemophilia from | phase japan | specialty market | study rviii | with immunoglobulins | patients clinical | products prophylaxis | bleeding breakthrough | rix-fp development | global medicines |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
functional activity (%) 40 IU/kg 1000 IU 60 IU/kg 40% activity SC low IU/kg SC high IU/kg IV 1000 IU/kg Specialty 59 CSL830 Program Progress • Phase III study rapidly completed enrollment (n=90) • Patients moving into extension study o Allowed for in data, CSL Actuals FY15 Total Global Market Value: ~$8.0B Immunoglobulins 42 CSL’s Global Performance CSL FY15 Sales $2.326B Key Brands: SCIG Hyper IVIG Immunoglobulins 43 0 20 40 60 80 100 120 140 India Thailand Russia Taiwan Braz
Text Inhalt Text aus URL
Log Metriken 446029
www.cslbehring.ch
Datum der Indexierung 25.04.2021 00:30:41
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords haemophilia program | phase market | specialty rviii | study immunoglobulins | products prophylaxis | patients research | with breakthrough | global medicines | development rix-fp | clinical bleeding |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
function (data from the RAPID trial)1,2 A1- PI No treatment Projected survival difference Lu ng d en sit y ( g/ L) Time (years) 60 50 40 30 20 10 0 5 10 15 20 -1.5 g/L/yr -2.2 g/L/yr ~6 years Terminal value Specialty 67 Commercial Opportunities and A data, CSL Actuals FY15 Total Global Market Value: ~$8.0B Immunoglobulins 42 CSL’s Global Performance CSL FY15 Sales $2.326B Key Brands: SCIG Hyper IVIG Immunoglobulins 43 0 20 40 60 80 100 120 140 India Thailand Russia Taiwan Braz
Text Inhalt Text aus URL
Log Metriken 563121
erkannte Namen Alex Gertsch | Gérard Jenni | Georg Ptak | Patricia Stutz | Corona Ladensterben |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 0 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description pdf
Kombination Keywords haemophilia program | phase market | specialty rviii | study immunoglobulins | products prophylaxis | patients research | with breakthrough | global medicines | development rix-fp | clinical bleeding |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
function (data from the RAPID trial)1,2 A1- PI No treatment Projected survival difference Lu ng d en sit y ( g/ L) Time (years) 60 50 40 30 20 10 0 5 10 15 20 -1.5 g/L/yr -2.2 g/L/yr ~6 years Terminal value Specialty 67 Commercial Opportunities and A data, CSL Actuals FY15 Total Global Market Value: ~$8.0B Immunoglobulins 42 CSL’s Global Performance CSL FY15 Sales $2.326B Key Brands: SCIG Hyper IVIG Immunoglobulins 43 0 20 40 60 80 100 120 140 India Thailand Russia Taiwan Braz
Text Inhalt Text aus URL
Log Metriken 563121